1-(tert-butyl) 3-methyl (3S,5R)-5-hydroxypiperidine-1,3-dicarboxylate

Catalog No.: 
ACZQHB839
CAS No.: 
2165488-07-1
Molecular Formula: 
C12H21NO5
Molecular Weight: 
259.30
1-(tert-butyl) 3-methyl (3S,5R)-5-hydroxypiperidine-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$594.00In stockInquiry
250mg95%$875.00In stockInquiry
500mg95%$1562.00In stockInquiry
1g95%$2499.00In stockInquiry
5g95%$7497.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-butyl) 3-methyl (3S,5R)-5-hydroxypiperidine-1,3-dicarboxylate
IUPAC Name1-(tert-butyl) 3-methyl (3S,5R)-5-hydroxypiperidine-1,3-dicarboxylate
Molecular FormulaC12H21NO5
Molecular Weight259.30
SMILESCOC(=O)[C@H]1C[C@@H](O)CN(C(=O)OC(C)(C)C)C1
InChI KeyDFZMPKMSTNKZKL-DTWKUNHWSA-N
Synonym1-(1,1-Dimethylethyl) 3-methyl (3S,5R)-5-hydroxy-1,3-piperidinedicarboxylate;O1-tert-butyl O3-methyl (3S,5R)-5-hydroxypiperidine-1,3-dicarboxylate;1,3-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-dimethylethyl) 3-methyl ester, (3S,5R)-
CAS No.2165488-07-1

Synthetic Route by SureRoute

1. ACZQHB839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZQHB839 route product structure diagram
    ACZQHB8392165488-07-1In Stock
Inquiry

2. ACZQHB839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQHB839 route product structure diagram
    ACZQHB8392165488-07-1In Stock
Inquiry

3. ACZQHB839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQHB839 route product structure diagram
    ACZQHB8392165488-07-1In Stock
Inquiry

Comments (0)